Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Controlled human malaria infection comparing three Plasmodium falciparum isolates
NL-OMON37044Active, not recruiting
- Sponsor
- Radboud University Medical Center
- Start
- Sep 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of atovaquone + proguanil in malaria (3 arms), sponsored by Radboud University Medical Center. Primary endpoint: Difference in parasitemia kinetics. Started Sep 2012; status: active, not recruiting.
02
Drugs
atovaquone + proguanil
03
Conditions
malaria
Beyond the preview
Go deeper on NL-OMON37044.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON37044.